Guardant Health, Inc. · NASDAQ:GH

Talasaz AmirAli sold 210,000 Guardant Health, Inc. shares (Form 4)

Traded May 20, 2026 · Filed May 22, 2026

On May 20, 2026, Talasaz AmirAli (Director, Co-Chief Executive Officer) sold 210,000 Guardant Health, Inc. shares at an average US$109.89 for US$23.1M under a trading plan, leaving 1,886,504 shares. Filed May 22, 2026 (Form 4).

Sold
210,000 shares
Price
US$109.89 average (US$100.95 to US$112.76)
Value
US$23.1M
Holding after
1,886,504 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Co-Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 20, 2026Common StockSale200US$100.952,096,304Indirect
May 20, 2026Common StockSale900US$102.572,095,404Indirect
May 20, 2026Common StockSale1,366US$103.822,094,038Indirect
May 20, 2026Common StockSale11,919US$105.012,082,119Indirect
May 20, 2026Common StockSale1,200US$105.882,080,919Indirect
May 20, 2026Common StockSale21,171US$106.992,059,748Indirect
May 20, 2026Common StockSale33,069US$108.112,026,679Indirect
May 20, 2026Common StockSale9,852US$108.972,016,827Indirect
May 20, 2026Common StockSale28,908US$110.101,987,919Indirect
May 20, 2026Common StockSale37,163US$111.141,950,756Indirect
May 20, 2026Common StockSale37,900US$112.021,912,856Indirect
May 20, 2026Common StockSale26,352US$112.761,886,504Indirect

Source

View original at SEC

Related